Gestational diabetes mellitus is a significant risk factor for long-term maternal renal disease

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 4, 2015, Pages 1412-1416

  Beharier, Ofer ^a   Shoham Vardi, Ilana ^b   Pariente, Gali ^a   Sergienko, Ruslan ^b   Kessous, Roy ^a   Baumfeld, Yael ^a   Szaingurten Solodkin, Irit ^b   Sheiner, Eyal ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DELIVERY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; ISRAEL; KAPLAN MEIER METHOD; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MATERNAL MORBIDITY; MATERNAL SMOKING; OBESITY; PARITY; POPULATION RESEARCH; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; UNIVERSITY HOSPITAL; DIABETES, GESTATIONAL; HOSPITALIZATION; KIDNEY DISEASES; MORBIDITY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; DIABETES, GESTATIONAL; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; INCIDENCE; KIDNEY DISEASES; MORBIDITY; PREGNANCY; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84927652532     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-4474     Document Type: Article

References (36)

1. Serlin DC, Lash RW. Diagnosis and management of gestational diabetes mellitus. Am Fam Physician. 2009;80:57-62.
2. Hunt KJ, Schuller KL. The increasing prevalence of diabetes in pregnancy. Obstet Gynecol Clin North Am. 2007;34:173-199, vii.
3. Lipscombe LL, Hux JE. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study. Lancet. 2007;369:750-756.
4. Chu SY, Callaghan WM, Kim SY, et al. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care. 2007;30:2070-2076.
5. Löbner K, Knopff A, Baumgarten A, et al. Predictors of postpartum diabetes in women with gestational diabetes mellitus. Diabetes. 2006;55:792-797.
6. Bottalico JN. Recurrent gestational diabetes: risk factors, diagnosis, management, and implications. Semin Perinatol. 2007;31:176-184.
7. Kim C, Berger DK, Chamany S. Recurrence of gestational diabetes mellitus: a systematic review. Diabetes Care. 2007;30:1314-1319.
8. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and metaanalysis. Lancet. 2009;373:1773-1779.
9. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2006;29(suppl 1):S43-S48.
10. Kuhl C. Insulin secretion and insulin resistance in pregnancy and GDM. Implications for diagnosis and management. Diabetes. 1991;40(suppl 2):18-24.
11. Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabet Med. 2004;21:103-113.
12. Gungor O, Gazi E, Ozkececi G, et al. Is abnormal glucose metabolism during pregnancy related to endothelial dysfunction? J Matern Fetal Neonatal Med. 2015;28:182-185.
13. Knock GA, McCarthy AL, Lowy C, Poston L. Association of gestational diabetes with abnormal maternal vascular endothelial function. Br J Obstet Gynaecol. 1997;104:229-234.
14. Lappas M. Markers of endothelial cell dysfunction are increased in human omental adipose tissue from women with pre-existing maternal obesity and gestational diabetes. Metabolism. 2014;63:860-873.
15. Bo S, Valpreda S, Menato G, et al. Should we consider gestational diabetes a vascular risk factor? Atherosclerosis. 2007;194:e72-e79.
16. Kessous R, Shoham-Vardi I, Pariente G, Sherf M, Sheiner E. An association between gestational diabetes mellitus and long-term maternal cardiovascular morbidity. Heart. 2013;99:1118-1121.
17. Vrachnis N, Augoulea A, Iliodromiti Z, Lambrinoudaki I, Sifakis S, Creatsas G. Previous gestational diabetes mellitus and markers of cardiovascular risk. Int J Endocrinol. 2012;2012:458610.
18. Collins AJ, Foley RN, Chavers B, et al. United States Renal Data System 2011 Annual Data Report: atlas of chronic kidney disease, end-stage renal disease in the United States. Am J Kidney Dis. 2012;59(suppl 1):A7, e1-e420.
19. Drüeke TB, Massy ZA. Atherosclerosis in CKD: differences from the general population. Nat Rev Nephrol. 2010;6:723-735.
20. Fraser A, Nelson SM, Macdonald-Wallis C, et al. Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children. Circulation. 2012;125:1367-1380.
21. Kessous R, Shoham-Vardi I, Pariente G, Holcberg G, Sheiner E. An association between preterm delivery and long-term maternal cardiovascular morbidity. Am J Obstet Gynecol. 2013;209:368.e1-368.e8.
22. Pariente G, Shoham-Vardi I, Kessous R, Sergienko R, Sheiner E. Is stillbirth associated with long-term atherosclerotic morbidity? Am J Obstet Gynecol. 2014;211:416.e1-416.e12.
23. Rich-Edwards JW, Fraser A, Lawlor DA, Catov JM. Pregnancy characteristics and women's future cardiovascular health: an underused opportunity to improve women's health? Epidemiol Rev. 2014;36:57-70.
24. The Central Bureau of Statistics. Israel in Figures 2013. http://wwwcbsgovil/www/publications/isr-in-n13epdf. Accessed February 15, 2015.
25. Carr DB, Utzschneider KM, Hull RL, et al. Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes. Diabetes Care. 2006;29:2078-2083.
26. Friedman S, Rabinerson D, Bar J, et al. Microalbuminuria following gestational diabetes. Acta Obstet Gynecol Scand. 1995;74:356-360.
27. Bomback AS, Rekhtman Y, Whaley-Connell AT, et al. Gestational diabetes mellitus alone in the absence of subsequent diabetes is associated with microalbuminuria: results from the Kidney Early Evaluation Program (KEEP). Diabetes Care. 2010;33:2586-2591.
28. Shankar A, Sun L, Klein BE, et al. Markers of inflammation predict the long-term risk of developing chronic kidney disease: a populationbased cohort study. Kidney Int. 2011;80:1231-1238.
29. Jenny NS, Tracy RP, Ogg MS, et al. In the elderly, interleukin-6 plasma levels and the-174G>Cpolymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol. 2002;22:2066-2071.
30. Udeanu M, Guizzardi G, Di Pasquale G, et al. Relationship between coronary artery disease and C-reactive protein levels in NSTEMI patients with renal dysfunction: a retrospective study. BMC Nephrol. 2014;15:152.
31. Hamsten A, de Faire U, Walldius G, et al. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet. 1987;2:3-9.
32. Winzer C, Wagner O, Festa A, et al. Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care. 2004;27:1721-1727.
33. Di Cianni G, Lencioni C, Volpe L, et al. C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes Metab Res Rev. 2007;23:135-140.
34. Volpe L, Cuccuru I, Lencioni C, et al. Early subclinical atherosclerosis in women with previous gestational diabetes mellitus. Diabetes Care. 2008;31:e32.
35. American Diabetes Association. Standards of medical care in diabetes-2012. Diabetes Care. 2012;35(suppl 1):S11-S63.
36. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA. 2004;291:2847-2850.